<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">35188856</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>16</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>01</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1744-5116</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>60</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Dec</Month>
            </PubDate>
          </JournalIssue>
          <Title>Pharmaceutical biology</Title>
          <ISOAbbreviation>Pharm Biol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>M2b macrophages stimulate lymphangiogenesis to reduce myocardial fibrosis after myocardial ischaemia/reperfusion injury.</ArticleTitle>
        <Pagination>
          <StartPage>384</StartPage>
          <EndPage>393</EndPage>
          <MedlinePgn>384-393</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/13880209.2022.2033798</ELocationID>
        <Abstract>
          <AbstractText Label="CONTEXT" NlmCategory="BACKGROUND">Therapeutic lymphangiogenesis is a new treatment for cardiovascular diseases. Our previous study showed M2b macrophages can alleviate myocardial ischaemia/reperfusion injury (MI/RI). However, the relation between M2b macrophages and lymphangiogenesis is not clear.</AbstractText>
          <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To investigate the effects of M2b macrophages on lymphangiogenesis after MI/RI.</AbstractText>
          <AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">Forty male Sprague-Dawley (SD) rats were randomized into Sham operation group (control, <i>n</i> = 8), MI/RI group (<i>n</i> = 16) and M2b macrophage transplantation group (<i>n</i> = 16). M2b macrophages (1 × 10<sup>6</sup>) in 100 μL of normal saline or the same volume of vehicle was injected into the cardiac ischaemic zone. Two weeks later, echocardiography and lymphatic counts were performed, and the extent of myocardial fibrosis and the expression of vascular endothelial growth factor C (VEGFC) and VEGF receptor 3 (VEGFR3) were determined. <i>In vitro,</i> lymphatic endothelial cells (LECs) were cultured with M2b macrophages for 6-24 h, and the proliferation, migration and tube formation of the LECs were assessed.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS"><i>In vivo,</i> M2b macrophage transplantation increased the level of lymphangiogenesis 2.11-fold, reduced 4.42% fibrosis, improved 18.65% left ventricular ejection fraction (LVEF) and upregulated the expressions of VEGFC and VEGFR3. <i>In vitro,</i> M2b macrophage increased the proliferation, migration, tube formation and VEGFC expression of LECs. M2b macrophage supernatant upregulated VEGFR3 expression of LECs.</AbstractText>
          <AbstractText Label="DISCUSSION AND CONCLUSIONS" NlmCategory="CONCLUSIONS">Our study shows that M2b macrophages can promote lymphangiogenesis to reduce myocardial fibrosis and improve heart function, suggesting the possible use of M2b macrophage for myocardial protection therapy.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Cuiping</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiothoracic ICU, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, PR China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Key Laboratory on Assisted Circulation, Ministry of Health, Guangzhou, PR China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yue</LastName>
            <ForeName>Yuan</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory on Assisted Circulation, Ministry of Health, Guangzhou, PR China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Cardiac Surgery, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, PR China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Huang</LastName>
            <ForeName>Suiqing</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory on Assisted Circulation, Ministry of Health, Guangzhou, PR China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Cardiac Surgery, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, PR China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Keke</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory on Assisted Circulation, Ministry of Health, Guangzhou, PR China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Cardiac Surgery, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, PR China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yang</LastName>
            <ForeName>Xiao</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Laboratory Medicine, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, PR China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Jiantao</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory on Assisted Circulation, Ministry of Health, Guangzhou, PR China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Cardiac Surgery, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, PR China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Huang</LastName>
            <ForeName>Jiaxing</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory on Assisted Circulation, Ministry of Health, Guangzhou, PR China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Cardiac Surgery, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, PR China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wu</LastName>
            <ForeName>Zhongkai</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory on Assisted Circulation, Ministry of Health, Guangzhou, PR China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Cardiac Surgery, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, PR China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Pharm Biol</MedlineTA>
        <NlmUniqueID>9812552</NlmUniqueID>
        <ISSNLinking>1388-0209</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002465" MajorTopicYN="N">Cell Movement</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D049109" MajorTopicYN="N">Cell Proliferation</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004452" MajorTopicYN="N">Echocardiography</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D042783" MajorTopicYN="N">Endothelial Cells</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005355" MajorTopicYN="N">Fibrosis</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D042583" MajorTopicYN="N">Lymphangiogenesis</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008264" MajorTopicYN="N">Macrophages</DescriptorName>
          <QualifierName UI="Q000637" MajorTopicYN="Y">transplantation</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015428" MajorTopicYN="N">Myocardial Reperfusion Injury</DescriptorName>
          <QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
          <QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011897" MajorTopicYN="N">Random Allocation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017207" MajorTopicYN="N">Rats, Sprague-Dawley</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013318" MajorTopicYN="N">Stroke Volume</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016277" MajorTopicYN="N">Ventricular Function, Left</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Cardiac fibrosis</Keyword>
        <Keyword MajorTopicYN="N">VEGF receptor 3</Keyword>
        <Keyword MajorTopicYN="N">VEGFC</Keyword>
      </KeywordList>
      <CoiStatement>The authors report that there are no relationships that could be construed as a conflict of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>21</Day>
          <Hour>17</Hour>
          <Minute>9</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35188856</ArticleId>
        <ArticleId IdType="pmc">PMC8865132</ArticleId>
        <ArticleId IdType="doi">10.1080/13880209.2022.2033798</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Banerji S, Ni J, Wang SX, Clasper S, Su J, Tammi R, Jones M, Jackson DG.. 
1999. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol. 144(4):789–801.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2132933</ArticleId>
            <ArticleId IdType="pubmed">10037799</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Breiteneder-Geleff S, Soleiman A, Kowalski H, Horvat R, Amann G, Kriehuber E, Diem K, Weninger W, Tschachler E, Alitalo K, et al. . 
1999. Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium. Am J Pathol. 154(2):385–394.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1849992</ArticleId>
            <ArticleId IdType="pubmed">10027397</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chanmee T, Ontong P, Konno K, Itano N.. 
2014. Tumor-associated macrophages as major players in the tumor microenvironment. Cancers. 6(3):1670–1690.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4190561</ArticleId>
            <ArticleId IdType="pubmed">25125485</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Choi I, Lee S, Hong YK.. 
2012. The new era of the lymphatic system: no longer secondary to the blood vascular system. Cold Spring Harb Perspect Med. 2(4):a006445.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3312397</ArticleId>
            <ArticleId IdType="pubmed">22474611</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cui Y, Urschel JD, Petrelli NJ.. 
2001. The effect of cardiopulmonary lymphatic obstruction on heart and lung function. Thorac Cardiovasc Surg. 49(1):35–40.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11243520</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Duerr GD, Heinemann JC, Suchan G, Kolobara E, Wenzel D, Geisen C, Matthey M, Passe-Tietjen K, Mahmud W, Ghanem A, et al. . 
2014. The endocannabinoid-CB2 receptor axis protects the ischemic heart at the early stage of cardiomyopathy. Basic Res Cardiol. 109(4):425.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24980781</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gensel JC, Zhang B.. 
2015. Macrophage activation and its role in repair and pathology after spinal cord injury. Brain Res. 1619:1–11.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25578260</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hagura A, Asai J, Maruyama K, Takenaka H, Kinoshita S, Katoh N.. 
2014. The VEGF-C/VEGFR3 signaling pathway contributes to resolving chronic skin inflammation by activating lymphatic vessel function. J Dermatol Sci. 73(2):135–141.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24252749</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hartikainen J, Hassinen I, Hedman A, Kivela A, Saraste A, Knuuti J, Husso M, Mussalo H, Hedman M, Rissanen TT, et al. . 
2017. Adenoviral intramyocardial VEGF-DΔNΔC gene transfer increases myocardial perfusion reserve in refractory angina patients: a phase I/IIa study with 1-year follow-up. Eur Heart J. 38(33):2547–2555.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5837555</ArticleId>
            <ArticleId IdType="pubmed">28903476</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Henri O, Pouehe C, Houssari M, Galas L, Nicol L, Edwards-Levy F, Henry JP, Dumesnil A, Boukhalfa I, Banquet S, et al. . 
2016. Selective stimulation of cardiac lymphangiogenesis reduces myocardial edema and fibrosis leading to improved cardiac function following myocardial infarction. Circulation. 133(15):1484–1497.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26933083</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang LH, Lavine KJ, Randolph GJ.. 
2017. Cardiac lymphatic vessels, transport, and healing of the infarcted heart. JACC Basic Transl Sci. 2(4):477–483.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5628514</ArticleId>
            <ArticleId IdType="pubmed">28989985</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hwang SD, Song JH, Kim Y, Lim JH, Kim MY, Kim EN, Hong YA, Chung S, Choi BS, Kim YS, et al. . 
2019. Inhibition of lymphatic proliferation by the selective VEGFR-3 inhibitor SAR131675 ameliorates diabetic nephropathy in DB/DB mice. Cell Death Dis. 10(3):219.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6399322</ArticleId>
            <ArticleId IdType="pubmed">30833548</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ishikawa Y, Akishima-Fukasawa Y, Ito K, Akasaka Y, Tanaka M, Shimokawa R, Kimura-Matsumoto M, Morita H, Sato S, Kamata I, et al. . 
2007. Lymphangiogenesis in myocardial remodelling after infarction. Histopathology. 51(3):345–353.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2366023</ArticleId>
            <ArticleId IdType="pubmed">17727476</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Joukov V, Pajusola K, Kaipainen A, Chilov D, Lahtinen I, Kukk E, Saksela O, Kalkkinen N, Alitalo K.. 
1996. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J. 15(2):290–298.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC449944</ArticleId>
            <ArticleId IdType="pubmed">8617204</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kinashi H, Ito Y, Mizuno M, Suzuki Y, Terabayashi T, Nagura F, Hattori R, Matsukawa Y, Mizuno T, Noda Y, et al. . 
2013. TGF-beta1 promotes lymphangiogenesis during peritoneal fibrosis. J Am Soc Nephrol. 24(10):1627–1642.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3785267</ArticleId>
            <ArticleId IdType="pubmed">23990681</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kinashi H, Ito Y, Sun T, Katsuno T, Takei Y.. 
2018. Roles of the TGF-beta(-)VEGF-C pathway in fibrosis-related lymphangiogenesis. Int J Mol Sci. 19(9):2487.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6163754</ArticleId>
            <ArticleId IdType="pubmed">30142879</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kong D, Kong X, Wang L.. 
2006. Effect of cardiac lymph flow obstruction on cardiac collagen synthesis and interstitial fibrosis. Physiol Res. 55:253–258.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16083309</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lohela M, Bry M, Tammela T, Alitalo K.. 
2009. VEGFs and receptors involved in angiogenesis versus lymphangiogenesis. Curr Opin Cell Biol. 21(2):154–165.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19230644</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lupinski RW.
2009. Aortic fat pad and atrial fibrillation: cardiac lymphatics revisited. ANZ J Surg. 79(1–2):70–74.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19183382</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Martinez FO, Gordon S.. 
2014. The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep. 6:13.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3944738</ArticleId>
            <ArticleId IdType="pubmed">24669294</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Martinez FO, Sica A, Mantovani A, Locati M.. 
2008. Macrophage activation and polarization. Front Biosci. 13:453–461.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17981560</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mills CD, Kincaid K, Alt JM, Heilman MJ, Hill AM.. 
2000. M-1/M-2 macrophages and the Th1/Th2 paradigm. J Immunol. 164(12):6166–6173.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10843666</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Niinimaki E, Mennander AA, Paavonen T, Kholova I.. 
2016. Lymphangiogenesis is increased in heart valve endocarditis. Int J Cardiol. 219:317–321.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27344132</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ochsenbein AM, Karaman S, Proulx ST, Goldmann R, Chittazhathu J, Dasargyri A, Chong C, Leroux JC, Stanley ER, Detmar M.. 
2016. Regulation of lymphangiogenesis in the diaphragm by macrophages and VEGFR-3 signaling. Angiogenesis. 19(4):513–524.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5026726</ArticleId>
            <ArticleId IdType="pubmed">27464987</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sainz-Jaspeado M, Claesson-Welsh L.. 
2018. Cytokines regulating lymphangiogenesis. Curr Opin Immunol. 53:58–63.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29680577</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shapouri-Moghaddam A, Mohammadian S, Vazini H, Taghadosi M, Esmaeili SA, Mardani F, Seifi B, Mohammadi A, Afshari JT, Sahebkar A.. 
2018. Macrophage plasticity, polarization, and function in health and disease. J Cell Physiol. 233(9):6425–6440.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29319160</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Suzuki Y, Ito Y, Mizuno M, Kinashi H, Sawai A, Noda Y, Mizuno T, Shimizu H, Fujita Y, Matsui K, et al. . 
2012. Transforming growth factor-β induces vascular endothelial growth factor-C expression leading to lymphangiogenesis in rat unilateral ureteral obstruction. Kidney Int. 81(9):865–879.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22258325</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>The National Academies Collection: Reports funded by National Institutes of Health. 
2011. Guide for the care and use of laboratory animals. Washington (DC): National Academies Press.</Citation>
        </Reference>
        <Reference>
          <Citation>Urbina P, Singla DK.. 
2014. BMP-7 attenuates adverse cardiac remodeling mediated through M2 macrophages in prediabetic cardiomyopathy. Am J Physiol-Heart C. 307(5):H762–772.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4187394</ArticleId>
            <ArticleId IdType="pubmed">24993041</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vaahtomeri K, Karaman S, Makinen T, Alitalo K.. 
2017. Lymphangiogenesis guidance by paracrine and pericellular factors. Genes Dev. 31(16):1615–1634.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5647933</ArticleId>
            <ArticleId IdType="pubmed">28947496</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vuorio T, Tirronen A, Yla-Herttuala S.. 
2017. Cardiac lymphatics – a new avenue for therapeutics?
Trends Endocrinol Metab. 28(4):285–296.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28087126</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang LX, Zhang SX, Wu HJ, Rong XL, Guo J.. 
2019. M2b macrophage polarization and its roles in diseases. J Leukoc Biol. 106(2):345–358.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7379745</ArticleId>
            <ArticleId IdType="pubmed">30576000</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Y, Huang H, Sun R, Chen B, Han F, Li Q, Ni Y, Li X, Liu J, Mou X, et al. . 
2017. Serum amyloid a induces M2b-like macrophage polarization during liver inflammation. Oncotarget. 8(65):109238–109246.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5752517</ArticleId>
            <ArticleId IdType="pubmed">29312604</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Y, Wehling-Henricks M, Samengo G, Tidball JG.. 
2015. Increases of M2a macrophages and fibrosis in aging muscle are influenced by bone marrow aging and negatively regulated by muscle-derived nitric oxide. Aging Cell. 14(4):678–688.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4531081</ArticleId>
            <ArticleId IdType="pubmed">26009878</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Watari K, Nakao S, Fotovati A, Basaki Y, Hosoi F, Bereczky B, Higuchi R, Miyamoto T, Kuwano M, Ono M.. 
2008. Role of macrophages in inflammatory lymphangiogenesis: enhanced production of vascular endothelial growth factor C and D through NF-kappaB activation. Biochem Biophys Res Commun. 377(3):826–831.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18951870</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wigle JT, Oliver G.. 
1999. Prox1 function is required for the development of the murine lymphatic system. Cell. 98(6):769–778.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10499794</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yamashita M, Iwama N, Date F, Shibata N, Miki H, Yamauchi K, Sawai T, Sato S, Takahashi T, Ono M.. 
2009. Macrophages participate in lymphangiogenesis in idiopathic diffuse alveolar damage through CCL19-CCR7 signal. Hum Pathol. 40(11):1553–1563.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19540558</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang GH, Zhou X, Ji WJ, Liu JX, Sun J, Dong Y, Jiang TM, Li YM.. 
2017. VEGF-C-mediated cardiac lymphangiogenesis in high salt intake accelerated progression of left ventricular remodeling in spontaneously hypertensive rats. Clin Exp Hypertens. 39(8):740–747.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28657345</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang M, Zheng J, Miao Y, Wang Y, Cui W, Guo J, Qiu S, Han Y, Jia L, Li H, et al. . 
2012. Serum-glucocorticoid regulated kinase 1 regulates alternatively activated macrophage polarization contributing to angiotensin II-induced inflammation and cardiac fibrosis. Arterioscler Thromb Vasc Biol. 32(7):1675–1686.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22556335</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yue Y, Yang X, Feng K, Wang L, Hou J, Mei B, Qin H, Liang M, Chen G, Wu Z.. 
2017. M2b macrophages reduce early reperfusion injury after myocardial ischemia in mice: a predominant role of inhibiting apoptosis via A20. Int J Cardiol. 245:228–235.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28764858</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
